Network Created to Promote Healthier Pregnancies in Michigan
Fourteen maternal-fetal medicine-focused universities and healthcare systems across the state are participating in SOS Maternity
Read More
Calif. Ballot Measure Targets Drug Discount Program Spending
Californians in November will weigh in on a ballot initiative to increase scrutiny over the use of health-care dollars — particularly money from a federal drug discount program — meant to support patient care largely for low-income or indigent people. The revenue is sometimes used to address housing instability and homelessness among vulnerable patient populations. Voters…
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Claire Zangerle, the American Hospital Association’s New Chief Nurse Executive
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that occurred recently in the healthcare sector. She also interviewed Claire Zangerle, who was appointed as chief nurse executive of the American Hospital Association, as well as CEO of its American Organization for Nursing Leadership. The post MedCity…
Opinions On the Veterans ACCESS Act Are Divided
The proposed bill would allow for more outsourcing of medical treatments to the private medical sector
Silence in Sikeston: Trauma Lives in the Body
SIKESTON, Mo. — At age 79, Nannetta Forrest, whose father, Cleo Wright, was lynched in Sikeston, Missouri, before she was born, wonders how the decades-long silence that surrounded his death in 1942 influenced her life. In 2020, Sikeston police killed another young Black man, 23-year-old Denzel Taylor. Taylor’s shooting death immediately made local headlines, but…
Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy
Rocket Pharmaceuticals voluntarily withdrew its FDA submission for its Fanconi anemia gene therapy. The move follows a corporate restructuring over the summer that refocused the company on its cardiovascular programs. The post Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy appeared first on MedCity News.
A structured approach for identifying disease analogs
Payers will often look to disease analogs when making pricing and coverage decisions. These disease analogs can inform the level of rebates, need for prior authorization/utilization management, and the drug’s cost sharing tier. Traditionally, however, disease analogs are selected on an ad hoc basis. In a recent JMCP paper titled “A structured approach for identifying…
Report: Medicaid Cuts Would Rip Away Health Coverage from Millions
If the House’s cuts become law, a third of all people of color relying on Medicaid would be disadvantaged
North Carolina’s Effort to Relieve Medical Debt
This policy watch examines the burden of medical debt in North Carolina and the state’s new plan to leverage the Medicaid program to provide debt relief and support access to care for low-income North Carolinians.
FDA’s Promised Rules on Pulse Oximeters Unlikely To End Decades of Racial Bias
OAKLAND, Calif. — The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well above the 88% blood oxygen saturation level that signals an urgent risk of organ failure and death. Yet his doctor, Noha Aboelata, believed the patient was sicker than the device showed. So…